About 1 result found for searched term "Cemdisiran, terminal sugar modification- " (0.125 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M28435 | Cemdisiran, terminal sugar modification- | Complement System |
| Cemdisiran, terminal sugar modification- is an investigational N-acetylgalactosamine-conjugated RNAi agent. Cemdisiran, a siRNA-targeting C5 mRNA, suppresses liver production of complement component C5. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
